MktsMarkets

Madrigal Pharmaceuticals, Inc.
NASDAQ: MDGLKey statistics
MDGL News
Stories mentioning MDGL from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 311,337 | 321,083 | 287,268 | 212,802 | 137,250 | 103,320 | 62,175 | 14,638 |
| Cost of Goods Sold | 4,513 | |||||||
| Gross Profit | 132,737 | |||||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 268,521 | 239,976 | 209,117 | 196,858 | 167,876 | 141,224 | 107,585 | 105,448 |
| Total Operating Expenses | 404,060 | 380,692 | 401,243 | 260,004 | 216,561 | 170,317 | 178,479 | 177,175 |
| Operating Income (Loss) | (92,723) | (59,609) | (113,975) | (47,202) | (79,311) | (66,997) | (116,304) | (162,537) |
| Interest Income | 8,243 | 9,459 | 10,308 | 8,227 | 9,370 | 11,079 | 13,019 | 14,222 |
| Interest Expense | 3,297 | 3,679 | 3,656 | |||||
| Other Expense | (2,092) | (128.00) | (293.00) | (42.00) | 0.00 | 0.00 | 0.00 | |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (94,391) | (58,575) | (114,190) | (42,281) | (73,238) | (59,416) | (106,964) | (151,971) |
| Earnings Per Share (Basic) | (3.25) | (2.61) | (4.01) | (1.50) | (2.61) | (2.79) | (4.92) | (7.10) |
| Earnings Per Share (Diluted) | (3.25) | (2.61) | (4.01) | (1.50) | (2.61) | (2.79) | (4.92) | (7.10) |
| Weighted Average Shares Outstanding (Basic) | 29,032 | 22,434 | 28,508 | 28,233 | 28,085 | 21,273 | 21,746 | 21,403 |
| Weighted Average Shares Outstanding (Diluted) | 29,032 | 22,434 | 28,508 | 28,233 | 28,085 | 21,273 | 21,746 | 21,403 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About MDGL
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is a stock listed on the Nasdaq Stock Market under the ticker symbol MDGL. It last traded at $431.15 (Nov 2, 2026, 4:00 PM ET), up 0.2% on the day. That gives Madrigal Pharmaceuticals a market capitalisation of $9.9B.
Over the past 52 weeks MDGL has traded between $399.00 and $615.00.
Revenue for the quarter ended Mar 31, 2026 was $311.3M; a net loss of $94.4M. Revenue was up 127% from $137.3M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $311.3M | -$94.4M | -30.3% |
| Dec 31, 2025 | $321.1M | -$58.6M | -18.2% |
| Sep 30, 2025 | $287.3M | -$114.2M | -39.8% |
| Jun 30, 2025 | $212.8M | -$42.3M | -19.9% |
From Madrigal Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…